US Proposes Crackdown of Chinese-Invented Treatments
The U.S. is considering tough restrictions on medicines and treatments invented in China, a move strongly opposed by U.S. pharmaceutical companies.
If enacted, American
In the News: US Biotech Restrictions Against China; China Regulates Non-Compete Clauses; and Hong Kong Stablecoins
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.
By Brian Chan